Tratamiento de la demodicosis canina generalizada con dosis reducidas de ivermectina oral

La administración diaria de ivermectina a dosis altas (0,6 mg/kg) es la mejor alternativa disponible para tratar aquellos casos de sarna demodécica resistente al almiraz

Humoral response (IgG) of goats experimentally infected with Fasciola hepatica against cysteine proteinases of adult fluke

The use of cysteine proteinases from Fasciola hepatica adult flukes for the serodiagnosis of caprine fasciolosis by means of an indirect ELISA test was studied. Two proteolytic fractions from adult fluke homogenates, with apparent molecular weights of 28 and 34 kDa (P28 and P34 respectively), were characterised as cysteine proteinases using azocasein assays and gelatin gel analysis. Both P28 and P34 fractions were electroluted and used as antigens in two different indirect ELISA tests. Serum IgG levels against P28 and P34 in goats given an experimental primary infection with 200 metacercariae or in goats given two experimental infections with 200 metacercariae were determined and compared with those observed in an uninfected control group. ELISA tests using both cysteine proteases showed a rapid and consistent detection of specific IgG in all experimentally infected goats. The IgG response to P28 was the first to be detected as early as 2–3 weeks post-infection and remained elevated throughout the experiment. The response to P34 was detected later (4–6 wpi) and disappeared in some animals at 18 wpi, while flukes were still present in the bile ducts. No significant differences were observed between the anti-P28 and anti-P34 IgG responses between animals receiving a primary or a challenge infection. The results of our study, although preliminary, are promising since the P28 ELISA described here may be a reliable method for the immunodiagnosis of F. hepatica infection in goats

Hypothenemus hampei (Coleoptera: Curculionidae) as in vitro inducer of laminarinase and chitinase of Beauveria bassiana (Hypocreales: Clavicipitaceae).

In Peru, Hypothenemus hampei or the coffee berry borer, (CBB) is the most important pest, causing specific damage to coffee crops, because it causes fruit to fall during feeding. On the other hand, Beauveria bassiana is an entomopathogenic fungus widely used in biological control. This study determine the induction of chitinase and laminarinase of B. bassiana in presence of H. hampei powder and how it relates to pathogenicity in order to promote the development of biological control agents and replace the use of pesticides. Three different liquid media cultures were prepared to induce the enzymatic production and growth of B. bassiana; and biomass, total proteins, conidia, enzymatic activities and enzymatic specific activities were evaluated. Data were analyzed using SPSS 19.0. Significant differences (P < 0.05) for biomass (F = 5.30; df = 35; P < 0.05), conidia (F = 190.87; df = 35; P < 0.05), total proteins (F = 91.04; df = 35; p < 0.05), laminarinase activity (F = 27.61; df = 35; P < 0.05), specific laminarinase activity (F = 25.31; df = 35; P < 0.05), chitinase activity (F = 32.66; df = 35; P < 0.05) and specific chitinase activity (F = 26.91; df = 35; P < 0.05) were determined between each treatment evaluated. Levels of chitinase and laminarinase determined that induction of these enzymes is possible in liquid media cultures supplemented with powdered H. hampei extract. Results require further evaluation for application in vivo but are fundamental and constitute a contribution to knowledge about the pathogenic mechanism of B. bassiana

Impact of COVID-19 on cardiovascular testing in the United States versus the rest of the world

Objectives: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-US institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic. Background: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality. Methods: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States. Results: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p < 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis. Conclusions: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection

Hypothenemus hampei (Coleoptera: Curculionidae) induce in vitro laminarinasa y quitinasa de Beauveria bassiana (Hypocreales: Clavicipitaceae)

In Peru, Hypothenemus hampei or the coffee berry borer, (CBB) is the most important pest, causing specific damage to coffee crops, because it causes fruit to fall during feeding. On the other hand, Beauveria bassiana is an entomopathogenic fungus widely used in biological control. This study determine the induction of chitinase and laminarinase of B. bassiana in presence of H. hampei powder and how it relates to pathogenicity in order to promote the development of biological control agents and replace the use of pesticides. Three different liquid media cultures were prepared to induce the enzymatic production and growth of B. bassiana; and biomass, total proteins, conidia, enzymatic activities and enzymatic specific activities were evaluated. Data were analyzed using SPSS 19.0. Significant differences (P &lt; 0.05) for biomass (F = 5.30; df = 35; P &lt; 0.05), conidia (F = 190.87; df = 35; P &lt; 0.05), total proteins (F = 91.04; df = 35; p &lt; 0.05), laminarinase activity (F = 27.61; df = 35; P &lt; 0.05), specific laminarinase activity (F = 25.31; df = 35; P &lt; 0.05), chitinase activity (F = 32.66; df = 35; P &lt; 0.05) and specific chitinase activity (F = 26.91; df = 35; P &lt; 0.05) were determined between each treatment evaluated. Levels of chitinase and laminarinase determined that induction of these enzymes is possible in liquid media cultures supplemented with powdered H. hampei extract. Results require further evaluation for application in vivo but are fundamental and constitute a contribution to knowledge about the pathogenic mechanism of B. bassiana.En el Perú, Hypothenemus hampei o broca es la plaga más importante, que causa daño específico a los cultivos de café, debido a que al momento de alimentarse provoca la caída de los frutos. De otro lado, Beauveria bassiana es un hongo entomopatógeno extensamente usado en el control biológico. Nuestra investigación determina la inducción de enzimas laminarinasa y quitinasa de B. bassiana en presencia de extracto en polvo de H. hampei y relacionarlas a su patogenicidad, para así promover el desarrollo de agentes de control biológico y sustituir el uso de plaguicidas. Se prepararon tres medios de cultivo líquido para inducir la producción enzimática y crecimiento de B. bassiana. Se evaluó la biomasa, proteínas totales, conidios, actividades enzimáticas y específicas de laminarinasa y quitinasa. Los datos se analizaron utilizando SPSS 19.0. Se encontraron diferencias significativas (P &lt; 0,05) para la biomasa (F = 5,30; df = 35; P &lt; 0,05), conidios (F = 190,87; df = 35; P &lt; 0,05), proteínas totales (F = 91,04; df = 35; P &lt; 0,05), la actividad laminarinasa (F = 27,61; df= 35; P &lt; 0,05), la actividad específica laminarinasa (F = 25,31), actividad quitinasa (F = 32,66; df = 35; P &lt; 0,05) y la actividad específica quitinasa (F = 26,91; df = 35; P &lt; 0,05). Los niveles de las enzimas laminarinasa y quitinasa en B. bassiana determinaron que la inducción de estas enzimas es posible en cultivo líquido suplementado con extracto en polvo de H. hampei. Los resultados requieren evaluaciones posteriores para la aplicación in vivo, sin embargo son fundamentales y constituyen aporte al conocimiento sobre el mecanismo patogénico de B. bassiana

Production of Sustainable Proteins Through the Conversion of Insects to Proteins Using Beauveria bassiana Cultures

Various strategies are being suggested to solve the challenges in the food system, such as changing the source of nutrients, including the use of non-traditional food sources such as insects. Although insects are promoted as a cheap and sustainable source of protein, consumers are reluctant to eat them. The mycoproteins produced by fungi, on the other hand, are very well received and appreciated by consumers. Thus, in this work we have studied the use of the entomopathogenic fungi Beauveria bassiana (Ascomycota: Hypocreales) for the production of protein using insects as feed. B. bassiana was cultivated in culture medium containing entire insects from the species Eurysacca and Hypothenemus or single carbon sources such as glucose or laminarin from Laminaria digitata. The results showed that B. bassiana can produce up to 16-fold more biomass and 8-fold more protein when grown in insect-based medium than when grown in glucose. The results also indicated that the production of proteins continuously increased when B. bassiana was grown in medium containing insects, reaching its maximum at 9 days (up to 3 mg/mL). On the other hand, when cultivated in glucose-supplemented medium, the production of proteins was constantly low (~0.5 mg/mL). In conclusion, B. bassiana was a large biomass producer and exuded a large amount of protein when grown in medium containing insect powder, making it an ideal intermediate link between insects and protein. Furthermore, the proteins produced by fungi such as B. bassiana can be used in the food, health, and cosmetic industries

Reduction of cardiac imaging tests during the COVID-19 pandemic: The case of Italy. Findings from the IAEA Non-invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID)

Background: In early 2020, COVID-19 massively hit Italy, earlier and harder than any other European country. This caused a series of strict containment measures, aimed at blocking the spread of the pandemic. Healthcare delivery was also affected when resources were diverted towards care of COVID-19 patients, including intensive care wards. Aim of the study: The aim is assessing the impact of COVID-19 on cardiac imaging in Italy, compare to the Rest of Europe (RoE) and the World (RoW). Methods: A global survey was conducted in May–June 2020 worldwide, through a questionnaire distributed online. The survey covered three periods: March and April 2020, and March 2019. Data from 52 Italian centres, a subset of the 909 participating centres from 108 countries, were analyzed. Results: In Italy, volumes decreased by 67% in March 2020, compared to March 2019, as opposed to a significantly lower decrease (p &lt; 0.001) in RoE and RoW (41% and 40%, respectively). A further decrease from March 2020 to April 2020 summed up to 76% for the North, 77% for the Centre and 86% for the South. When compared to the RoE and RoW, this further decrease from March 2020 to April 2020 in Italy was significantly less (p = 0.005), most likely reflecting the earlier effects of the containment measures in Italy, taken earlier than anywhere else in the West. Conclusions: The COVID-19 pandemic massively hit Italy and caused a disruption of healthcare services, including cardiac imaging studies. This raises concern about the medium- and long-term consequences for the high number of patients who were denied timely diagnoses and the subsequent lifesaving therapies and procedures

International Impact of COVID-19 on the Diagnosis of Heart Disease

Background: The coronavirus disease 2019 (COVID-19) pandemic has adversely affected diagnosis and treatment of noncommunicable diseases. Its effects on delivery of diagnostic care for cardiovascular disease, which remains the leading cause of death worldwide, have not been quantified. Objectives: The study sought to assess COVID-19's impact on global cardiovascular diagnostic procedural volumes and safety practices. Methods: The International Atomic Energy Agency conducted a worldwide survey assessing alterations in cardiovascular procedure volumes and safety practices resulting from COVID-19. Noninvasive and invasive cardiac testing volumes were obtained from participating sites for March and April 2020 and compared with those from March 2019. Availability of personal protective equipment and pandemic-related testing practice changes were ascertained. Results: Surveys were submitted from 909 inpatient and outpatient centers performing cardiac diagnostic procedures, in 108 countries. Procedure volumes decreased 42% from March 2019 to March 2020, and 64% from March 2019 to April 2020. Transthoracic echocardiography decreased by 59%, transesophageal echocardiography 76%, and stress tests 78%, which varied between stress modalities. Coronary angiography (invasive or computed tomography) decreased 55% (p &lt; 0.001 for each procedure). In multivariable regression, significantly greater reduction in procedures occurred for centers in countries with lower gross domestic product. Location in a low-income and lower–middle-income country was associated with an additional 22% reduction in cardiac procedures and less availability of personal protective equipment and telehealth. Conclusions: COVID-19 was associated with a significant and abrupt reduction in cardiovascular diagnostic testing across the globe, especially affecting the world's economically challenged. Further study of cardiovascular outcomes and COVID-19–related changes in care delivery is warranted

Impact of COVID-19 on Diagnostic Cardiac Procedural Volume in Oceania: The IAEA Non-Invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID)

Objectives: The INCAPS COVID Oceania study aimed to assess the impact caused by the COVID-19 pandemic on cardiac procedure volume provided in the Oceania region. Methods: A retrospective survey was performed comparing procedure volumes within March 2019 (pre-COVID-19) with April 2020 (during first wave of COVID-19 pandemic). Sixty-three (63) health care facilities within Oceania that perform cardiac diagnostic procedures were surveyed, including a mixture of metropolitan and regional, hospital and outpatient, public and private sites, and 846 facilities outside of Oceania. The percentage change in procedure volume was measured between March 2019 and April 2020, compared by test type and by facility. Results: In Oceania, the total cardiac diagnostic procedure volume was reduced by 52.2% from March 2019 to April 2020, compared to a reduction of 75.9% seen in the rest of the world (p&lt;0.001). Within Oceania sites, this reduction varied significantly between procedure types, but not between types of health care facility. All procedure types (other than stress cardiac magnetic resonance [CMR] and positron emission tomography [PET]) saw significant reductions in volume over this time period (p&lt;0.001). In Oceania, transthoracic echocardiography (TTE) decreased by 51.6%, transoesophageal echocardiography (TOE) by 74.0%, and stress tests by 65% overall, which was more pronounced for stress electrocardiograph (ECG) (81.8%) and stress echocardiography (76.7%) compared to stress single-photon emission computerised tomography (SPECT) (44.3%). Invasive coronary angiography decreased by 36.7% in Oceania. Conclusion: A significant reduction in cardiac diagnostic procedure volume was seen across all facility types in Oceania and was likely a function of recommendations from cardiac societies and directives from government to minimise spread of COVID-19 amongst patients and staff. Longer term evaluation is important to assess for negative patient outcomes which may relate to deferral of usual models of care within cardiology